Mesalamine Prolonged Release Tablets IP

Get a Price/Quote

MOQ : 20 Boxes

Mesalamine Prolonged Release Tablets IP Specification

Dosage Form
Prolonged Release Tablet

Pacakaging (Quantity Per Box)
10 strips of 10 tablets each

Origin of Medicine
India

Packaging Type
Blister pack

Indication
Ulcerative Colitis, Inflammatory Bowel Disease, Crohns Disease

Life Span
Refer to pack for expiry date

Salt Composition
Mesalamine 1200 mg

Drug Type
Allopathic

Ingredients
Mesalamine (Mesalazine)

Physical Form
Tablet

Function
Anti-inflammatory (for GI tract)

Recommended For
Patients with Inflammatory Bowel Disease (IBD), Ulcerative Colitis, Crohns Disease

Dosage
As directed by physician

Dosage Guidelines
Swallow whole, do not chew or crush

Suitable For
Adults

Quantity
10 tablets per strip

Storage Instructions
Store in a cool, dry place, away from direct sunlight

Marketed By
Wellspring Healthcare Private Limited

Administration Route
Oral

Therapeutic Class
Gastroenterology

Main Features
Once-daily dosing, Prolonged release formulation, Targeted colonic delivery

Brand Name
Meslamark OD

Color
Red

Prescription/Non Prescription
Prescription

Mesalamine Prolonged Release Tablets IP Trade Information

Minimum Order Quantity
20 Boxes

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Boxes Per Month

Delivery Time
2-5 Days

Main Domestic Market
All India

About Mesalamine Prolonged Release Tablets IP

Meslamark OD-Mesalamine Prolonged Release Tablets IP-delivers a resplendent standard in gastroenterology, earning favorable reviews from clinicians and patients alike. Its unassailable, top-drawer formulation ensures prolonged, targeted colonic release to alleviate symptoms in adults with Inflammatory Bowel Disease, Ulcerative Colitis, or Crohn's Disease. With a once-daily dosing regimen, each red tablet is conveniently blister-packed for ease of storage. Marketed by Wellspring Healthcare at the lowest price point, simply add to cart for a prescription-only solution trusted across India.

Advanced Features and Precise Application

Mesalamine Prolonged Release Tablets IP stand out with once-daily, prolonged action, launching targeted anti-inflammatory effects directly within the colon. Ideal for adults managing Inflammatory Bowel Disease, Ulcerative Colitis, and Crohn's Disease, its usage type demands prescription oversight. Carefully crafted for robust performance in gastroenterological care, the tablets exhibit sustained release and convenient oral administration, maximizing symptom control for those who need precision in their therapeutic regimen.

Delivery, Sample Policy & Shipping Valuation

Upon order confirmation, your Mesalamine Prolonged Release Tablets IP are promptly dispatched from India, ensuring swift arrival via the designated FOB port. Our exchange and sample policies are crafted for assurance-samples furnished upon request under mutually agreed terms. Each package undergoes meticulous valuation before shipment. Customers can expect transparent processes and reliable delivery timelines, enhancing your sourcing experience with steadfast focus on quality and logistical efficiency.

FAQ's of Mesalamine Prolonged Release Tablets IP:

Q: How should Meslamark OD Mesalamine Prolonged Release Tablets be taken?

A: Meslamark OD should be swallowed whole (do not chew or crush) once daily, exactly as directed by your physician. Follow all dosage guidelines provided on your prescription.

Q: What are the main benefits of Mesalamine Prolonged Release Tablets IP?

A: The main benefits include targeted anti-inflammatory action in the colon, reduced dosing frequency with once-daily administration, and a prolonged release mechanism for sustained therapeutic effects.

Q: When can patients expect symptom relief with Meslamine Prolonged Release Tablets IP?

A: Patients may begin to notice improvement in symptoms within a few days to a couple of weeks, though response times can vary based on individual health conditions and the severity of disease.

Q: Where should Meslamark OD be stored for optimal effectiveness?

A: Store the tablets in a cool, dry place away from direct sunlight. Always keep them in their original blister packaging until use to preserve efficacy.

Q: What is the process for exchanging or obtaining a sample of the product?

A: Samples can be provided upon request under standard sample policy conditions. For exchanges, contact your supplier to initiate the process in line with company protocols.

Q: Who is the ideal patient for Mesalamine Prolonged Release Tablets IP?

A: Adults diagnosed with Inflammatory Bowel Disease, Ulcerative Colitis, or Crohn's Disease, and who require a prescription-based, prolonged release therapy, are best suited for this medication.

Tell us about your requirement